APA (7th ed.) Citation

FG, R., AM, S., M, S., MP, L., ME, M. G., V, d. W., . . . JA, F. (2011). MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast cancer research and treatment, 127(1), 43. https://doi.org/10.1007/s10549-010-0940-x

Chicago Style (17th ed.) Citation

FG, Rodríguez-González, Sieuwerts AM, Smid M, Look MP, Meijer-van Gelder ME, de Weerd V, Sleijfer S, Martens JW, and Foekens JA. "MicroRNA-30c Expression Level Is an Independent Predictor of Clinical Benefit of Endocrine Therapy in Advanced Estrogen Receptor Positive Breast Cancer." Breast Cancer Research and Treatment 127, no. 1 (2011): 43. https://doi.org/10.1007/s10549-010-0940-x.

MLA (9th ed.) Citation

FG, Rodríguez-González, et al. "MicroRNA-30c Expression Level Is an Independent Predictor of Clinical Benefit of Endocrine Therapy in Advanced Estrogen Receptor Positive Breast Cancer." Breast Cancer Research and Treatment, vol. 127, no. 1, 2011, p. 43, https://doi.org/10.1007/s10549-010-0940-x.